Transformation of nonfunctioning pancreatic tumor into malignant insulinoma after 3 years: an uncommon clinical course of insulinoma
Open Access
- 1 June 2015
- journal article
- case report
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 59 (3) , 270-272
Abstract
A 62-year-old man admitted to our outpatient clinic with two months of recurrent life threatening hypoglycemia episodes. He was diagnosed as malignant insulinoma with multiple metastases of liver and peripancreatic lymph nodes. Liver biopsy specimen was demonstrated grade 2 neuroendocrine tumor compatible with clinical and radiological results. He was followed under the treatment of continuous intravenous glucose infusion during the diagnostic procedures. He had a pancreatic lesion history measured 20 x 12 mm in diameter via the abdominal tomography examination approximately two years before the diagnosis. Unusual course of this case suggests the transformation of nonfunctioning pancreatic neuroendocrine tumor into functional insulin secreting tumor with metastases. The patient was found inoperable and started on chemotherapy. Arch Endocrinol Metab. 2015;59(3):270-2Keywords
This publication has 10 references indexed in Scilit:
- Diagnosis and management of insulinomaWorld Journal of Gastroenterology, 2013
- Transformation of Nonfunctioning Pancreatic Neuroendocrine Carcinoma Cells into Insulin Producing Cells after Treatment with SunitinibEndocrinology and Metabolism, 2013
- PDGF signalling controls age-dependent proliferation in pancreatic β-cellsNature, 2011
- New therapeutic options for metastatic malignant insulinomasClinical Endocrinology, 2011
- A Unique Case of a Nonfunctional Metastatic Pancreatic Neuroendocrine Tumor Transforming Into an Insulin-Secreting Tumor With an Unusual Clinical CoursePancreas, 2011
- Insulinoma2009
- Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumoursEndocrine-Related Cancer, 2008
- Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumorsCancer, 2008
- Molecular parameters associated with insulinoma progression: chromosomal instability versus p53 and CK19 statusCytogenetic and Genome Research, 2006
- Pancreatic endocrine tumors: Immunocytochemical analysis of 125 tumorsHuman Pathology, 1982